IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
Read moreTue, 23rd Jul 2013 16:21
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
Read moreIN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
Read more(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.
Read moreCORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead
Read moreAIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win
Read moreScancell Assessing SCIB2 Options As Cancer Research UK Pact Ends
Read moreIN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine
Read moreOxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit
Read moreUK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
Read moreScancell Shares Rise As It Chooses Vaccine Candidate For Development
Read more(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.
Read moreDIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares
Read moreUK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares
Read moreUK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million
Read moreUK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves
Read more